RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
+30.7%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$228M
AUM Growth
+$228M
(+27%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.63B
| $147M | 64.43% |
2,936,507
| – | – |
|
2
Cytokinetics
CYTK
$4.23B
| $51.8M | 22.73% |
980,392
| – | – |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $29.2M | 12.84% |
3,846,154
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $851 | ﹤0.01% |
3,700
| – | – |
|